Related Experiment Video
Updated: May 5, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Neuro-Oncology Biotech Industry Progress Report 2025
Zoey A Croft1, Griffin Thomas1, Evan Keister1
1Neurosurgery, Lenox Hill Hospital, New York, USA.
Abstract:
Neuro-oncology is central to the rapidly expanding field of cancer therapeutics, with surges in clinical trials exploring innovative treatment strategies. The 2025 Brain Tumor Biotech Summit was hosted by Northwell Health Lenox Hill Hospital's Department of Neurosurgery, the Feinstein Institute for Medical Research, and the Zucker School of Medicine in New York City in June 2025. The summit highlighted recent advancements in neuro-oncology, with a focus on emerging treatments, novel drug delivery platforms, and device-based therapeutics. Leaders from academia, biotechnology, and investment communities presented progress on clinical trials, early-phase technologies, and personalized treatment strategies for glioblastoma (GBM) and other CNS tumors. This report summarizes the key discussions at the summit and emphasizes the importance of translational partnerships in accelerating therapy development for glioma patients.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Treatment Resistant Cancers
Treatment Resistent Cancers

